OBIEE is a comprehensive business intelligence platform that delivers a full range of analytic and reporting capabilities. Designed for scalability, reliability, and performance, OBIEE delivers contextual, relevant and actionable insight to everyone in an organization, resulting in improved decision-making, better-informed actions, and more efficient business processes. The Office of Financial Management (OFM) is implementing this business intelligence platform to provide enhanced financial reporting capabilities from our Unified Financial Management System (UFMS).The successful implementation of Oracle Business Intelligence Enterprise Edition (OBIEE) allows the FDA to improve the management of financial resources and improve reporting capabilities. The Office of Financial Operations works directly with each program by training and creating managerial and operational reports in order to meet analytical and managerial reporting needs. OBIEE also provides the flexibility to bring in other HHS and FDA data sources in areas such as Human Resources, Acquisitions, Program, etc).A. Develop statement of work and award Contract9/30/2008Completed9/30/2008B. Procure Hardware from Health and Human Services (HHS)1/31/2009Completed4/30/2009C. Gather Phase 1 Business Requirements (2)11/30/2009Completed11/30/2009D. Deploy Proof of Concept (POC) to Office of Financial Management (OFM) and Center for Veterinary Management (CVM) and complete Phase I User Acceptance Testing (3)4/30/2010Completed4/30/2010E. Gather Phase II Business Requirements11/30/2010Completed11/30/2010F. Complete Phase II User Acceptance Testing12/31/2010Completed12/31/2010G. Complete Phase II by implementing OBIEE across all FDA Centers1/31/2011 <i>(3/1/2011)</i>Completed3/1/2011(1) The dates in italics under the milestone due dates are revised milestone due dates which had to be updated due to real-time delays. The milestone status reflects the revised due dates.(2) Phase I is the deployment of OBIEE to OFM and CVM. Phase II is the deployment of OBIEE to the rest of FDA.(3) A Proof of Concept was conducted to determine OBIEE product capabilities and its gaps in meeting the FDA reporting requirements.http://www.fda.gov/AboutFDA/Transparency/track/ucm206310.htmFDA-TRACK Office of Operations Dashboard